ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1473

Expression of Vitamin D Receptor Associated Genes in the Aorta of Coronary Artery Disease Patients with and without Rheumatoid Arthritis

Ingvild Oma1, Sverre Holm2,3, Jacqueline Kirsti Andersen4, Ole K. Olstad5, Ida G. Fostad6, Torstein Lyberg5, Sven Martin Almdahl7, Øyvind Molberg8 and Ivana Hollan9,10,11, 1Innlandet Hospital Trust, Lillehammer, Norway, 2Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway, 3Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, 4Norwegian University of Science and Technology, Gjøvik, Norway, 5Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway, 6Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway, 7Department of Cardiothoracic Surgery, University Hospital of North Norway, Tromsø, Norway, 8Oslo University Hospital, Oslo, Norway, 9Brigham and Women’s Hospital, Boston, MA, 10Harvard Medical School, Boston, MA, 11Lillehammer Hospital for Rheumatic Diseases, Lillahammer, Norway

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Atherosclerosis, coronary artery disease and rheumatoid arthritis (RA), Gene Expression, Vitamin D

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Vitamin D has an important role in the immune system, and has been linked to inflammation, rheumatoid arthritis (RA) and coronary artery disease (CAD)[1, 2]. However, the exact mechanisms how vitamin D is involved in these processes are still unclear. Therefore, the aim of this study was to compare the expression of vitamin D receptor (VDR) associated genes in the aortic adventitia of CAD patients with and without RA.

Methods: RNA was isolated, and Affymetrix microarray was used to determine the gene expression profile in specimens from the ascending aorta in 8 patients with CAD and 8 patients with CAD and RA from the Feiring Heart Biopsy Study. Partek Genomics Suite software was used to identify differentially expressed genes by one-way ANOVA (p<0.05; FC>1.1), and differences in expression of VDR associated genes were determined by Ingenuity Pathway Analysis.

Results: Among the 15586 transcripts that were identified, pathway analysis determined two genes within the VDR signaling pathway, Growth arrest and DNA-damage-inducible protein 45 alpha (GADD45A) (p=0.006; FC=1.474) and Nuclear Receptor Corepressor 1 (NCOR1) (p=0.005; FC=1,210), that where both up-regulated in RA patients.

Conclusion: GADD45A induces cell cycle arrest, DNA repair and apoptosis in response to various environmental stresses [3], and NCOR1 has an important role as a gene-specific integrator of positive and negative signals that control inflammation [4]. In theory, the accelerated atherosclerosis in RA might be related to the up-regulation of GADD45A and NCOR1 through the VDR signaling pathway. 1. Urruticoechea-Arana, A., et al., Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study. Arthritis Res Ther, 2015. 17: p. 211.

2. Norman, P.E. and J.T. Powell, Vitamin D and cardiovascular disease. Circ Res, 2014. 114(2): p. 379-93.

3. Rosemary Siafakas, A. and D.R. Richardson, Growth arrest and DNA damage-45 alpha (GADD45alpha). Int J Biochem Cell Biol, 2009. 41(5): p. 986-9.

4. Glass, C.K. and K. Saijo, Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol, 2010. 10(5): p. 365-76.


Disclosure: I. Oma, None; S. Holm, None; J. K. Andersen, None; O. K. Olstad, None; I. G. Fostad, None; T. Lyberg, None; S. M. Almdahl, None; Ø. Molberg, None; I. Hollan, South-Eastern Norway Regional Health Authority, 2,the Norwegian Society for Rheumatology, 2,the Norwegian Rheumatism Association of the Norwegian Women’s Public Health Association, 2.

To cite this abstract in AMA style:

Oma I, Holm S, Andersen JK, Olstad OK, Fostad IG, Lyberg T, Almdahl SM, Molberg Ø, Hollan I. Expression of Vitamin D Receptor Associated Genes in the Aorta of Coronary Artery Disease Patients with and without Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/expression-of-vitamin-d-receptor-associated-genes-in-the-aorta-of-coronary-artery-disease-patients-with-and-without-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expression-of-vitamin-d-receptor-associated-genes-in-the-aorta-of-coronary-artery-disease-patients-with-and-without-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology